CERo Therapeutics Holdings, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 2.54 million compared to USD 0.667736 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +1.46% | -2.11% | -87.36% |
Apr. 02 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-87.36% | 20.17M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023